Our Mission in Action
Thermo Fisher Scientific's Corporate Social Responsibility (CSR) Report details our environmental, social, governance and financial performance.
Thermo Fisher Scientific Joins Cancer Moonshot Effort
As part of its ongoing effort to help advance research in liquid biopsy-based precision oncology, Thermo Fisher agreed to join the White House-led Cancer Moonshot initiative as a group partner in the Blood Profiling Atlas pilot
Welcome FEI
Thermo Fisher completed its acquisition of FEI Company, Inc., the leader in high-performance electron microscopy, for $107.50 per share in cash, or a total purchase price of approximately $4.2 billion.